Considerations on the implementation of MAP4K4 inhibitors as cancer treatment

Jaime Gonzalez-Montero; Mauricio Burotto

doi:10.1080/14728222.2024.2326211

Considerations on the implementation of MAP4K4 inhibitors as cancer treatment

Jaime Gonzalez-Montero, Mauricio Burotto^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

Original language	English
Journal	Expert Opinion on Therapeutic Targets
DOIs	https://doi.org/10.1080/14728222.2024.2326211
State	Accepted/In press - 2024
Externally published	Yes

Keywords

cancer
MAP4K4
MAP4K4 inhibitors
miRNA
targeted therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/14728222.2024.2326211

Cite this

@article{6537242ab9644d82b72ac7a35333d371,

title = "Considerations on the implementation of MAP4K4 inhibitors as cancer treatment",

keywords = "cancer, MAP4K4, MAP4K4 inhibitors, miRNA, targeted therapy",

author = "Jaime Gonzalez-Montero and Mauricio Burotto",

year = "2024",

doi = "10.1080/14728222.2024.2326211",

language = "English",

journal = "Expert Opinion on Therapeutic Targets",

issn = "1472-8222",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Considerations on the implementation of MAP4K4 inhibitors as cancer treatment

AU - Gonzalez-Montero, Jaime

AU - Burotto, Mauricio

PY - 2024

Y1 - 2024

KW - cancer

KW - MAP4K4

KW - MAP4K4 inhibitors

KW - miRNA

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85186880523&partnerID=8YFLogxK

U2 - 10.1080/14728222.2024.2326211

DO - 10.1080/14728222.2024.2326211

M3 - Editorial

C2 - 38421000

AN - SCOPUS:85186880523

SN - 1472-8222

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

ER -

Considerations on the implementation of MAP4K4 inhibitors as cancer treatment

Keywords

UN SDGs

Access to Document

Other files and links

Cite this